Team reveals miR-29 as regulator of processes for normal brain maturation
Researchers have shown that miR-29 can control brain maturation in mammals, presenting a target for autism, epilepsy and other conditions.
List view / Grid view
Researchers have shown that miR-29 can control brain maturation in mammals, presenting a target for autism, epilepsy and other conditions.
Sahm Nasseri discusses promising pre-clinical results of an RNA-based therapeutic developed to treat retinitis pigmentosa type 11.
In this application note, discover how pools of synthetic crRNAs can produce a phenotype as strong as, or stronger, than any one of the component crRNAs in arrayed CRISPR screening experiments.
Promising results have been shown in an animal model of Alzheimer's disease treated with zinc finger protein transcription factors.
SARS-CoV-2 diverts building blocks from glucose production to the assembly of purine bases, researchers have found.
A team has revealed a function of ADAR1, responsible for RNA editing, discovering an isoform used for cancer growth, making it a drug target.
Sequencing and transcriptome data on iPSCs has been used to identify correlations between genetic variants and expression patterns.
Researchers have developed a new technique called mim-tRNAseq to measure, map and analyse tRNAs in cells, providing insight into disease.
A fluorescence imaging technique has allowed scientists to observe RNA in real time using single-molecule localisation microscopy.
Using single-cell RNA sequencing, researchers have shown that interferon response is correlated with tuberculosis progression.
A study has shown that targeting the protein Nsp1 can inhibit genes for viral replication, which could lead to new COVID-19 treatments.
Researchers have discovered that two enzymes called APOBEC3C and ADAR1 work together to fuel the transition from pre-cancer stem cells to cancer stem cells in leukaemia.
21 January 2021 | By Yokogawa Life Innovations
Watch our on-demand webinar and learn how image-based phenotypic screening relies on extraction of multivariate information from cells cultured in a large number of screened conditions. In this webinar, we explore the application of complex and biologically relevant model systems for drug screening, such as small intestinal organoids.
Researchers suggest that identifying new treatments for autoimmune diseases requires studying the immune system AND target tissues together.
Scientists have created a drug discovery platform that enables the discovery and optimisation of RNA-targeting compounds.